On September 28, 2017, MaxWell Biosystems’ VP of Scientific Affairs, Michele Fiscella, travelled to London to meet with stem cell researchers from academia, and the pharma and biotech industries. Michele presented results from using the MaxOne platform with induced pluripotent stem cells (iPSCs) in a presentation titled, “High-resolution microelectrode array platform for biomarker discovery and novel functional assays with human iPSC-derived neurons.”

 

After presenting promising results and receiving a positive reception from researchers at iForum, Michele is excited about the potential for using MaxWell Biosystems’ HD-MEA technology in combination with human iPSC-derived neurons. He believes the high resolution in vitro system can accelerate and augment biomarker discovery and assay development for researchers.